Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
about
Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Smart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriersCo-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumorsReformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index.Self-Monitoring Artificial Red Cells with Sufficient Oxygen Supply for Enhanced Photodynamic TherapyFolic acid-conjugated soybean protein-based nanoparticles mediate efficient antitumor ability in vitro.Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells.A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.Applications of nanoparticle drug delivery systems for the reversal of multidrug resistance in cancer.Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics.The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.Transmembrane delivery of anticancer drugs through self-assembly of cyclic peptide nanotubes.Nanoscale characterization illustrates the cisplatin-mediated biomechanical changes of B16-F10 melanoma cells.Liposomal formulation for co-delivery of paclitaxel and lapatinib, preparation, characterization and optimization.Heteromer Nanostars by Spontaneous Self-Assembly.Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy.Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates.Successful treatment of ovarian cancer with apatinib combined with chemotherapy: A case report.Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles.Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance.Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment.Multilayer photodynamic therapy for highly effective and safe cancer treatment.Preparation of the Multifunctional Liposome-Containing Microneedle Arrays as an Oral Cavity Mucosal Vaccine Adjuvant-Delivery System.Nanoparticle hardness controls the internalization pathway for drug delivery.Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.Leveraging Physiology for Precision Drug Delivery
P2860
Q26778701-40E45E17-65E7-45B8-A29F-A7A0E9A283F1Q28073956-3418876B-A70A-4680-A149-D0A9FD4410F3Q28078448-ADC4FE26-9044-47E3-8214-5EA9CDF09706Q28817755-F983FAD1-8108-4269-A6CF-85B19E07B1C3Q33634653-5B286C0B-3BD2-4D55-A19A-CF671306D00AQ33712145-8847D3FE-1C7D-42C6-BFFE-4ED6A2EDF4AEQ35917427-FF7DB4C3-FF5E-4DE9-8998-49509E433272Q35961483-6900BB44-B365-44E9-9E69-677ACA5CF799Q36203093-6B419550-DADF-4A4D-A95E-CDAF416098C3Q36544608-7C0FFE3B-ADC2-4F87-86BD-797A2331D560Q36951434-A3D92879-6153-4302-8A37-BC6C219019DAQ37002153-C311C365-D354-4475-B44D-2097A563B55FQ37404658-9096152F-7C07-409B-A284-4CB0F0EC64C5Q37576360-6486A5DE-2E8F-40A4-A6EA-AA03A023CE4EQ38567353-7225F6CD-F271-4AC8-88B8-BFE2B1E0DC7AQ38776676-E7815974-2B4C-4743-AFC1-88E5652CC4AAQ38787285-6C2AF541-23E4-4B67-994C-CC7C858AF6DEQ38793427-F178242E-75CF-4945-B741-93B021FC6BF1Q38844243-C79AD47F-763E-4D69-8A00-52BC0DD61683Q41035496-030ADA38-97C8-4FD7-B570-96C1F1915625Q42229140-0AC2BFC0-DB96-4FEC-93B7-238A09313695Q44855222-DEA72A79-5D5E-4D7D-84BF-64ADC29D5D1EQ45711840-87996F6E-685A-4765-9D5C-8460A9A6600AQ47093736-4F84158A-7720-4CD4-BD18-A52BF212C08FQ48014782-F47BCC4A-E436-4F7D-8479-722601ECFAC9Q48862997-F15E5E02-4D85-4EDA-B6B3-DCAB33066573Q49788112-DFA3B64E-10F7-41DF-B405-8D30608CEA5FQ50113740-60D32135-5066-41CF-810F-34B1429E1180Q50675905-E1094000-A232-499A-8D2C-34843BB59996Q51372193-D1688A36-F186-4A81-BE04-FEBCBE7E1441Q53638970-AC56FA16-7F77-4053-AAAA-758EED273B26Q54958449-788D1D10-3503-47A4-AE57-5697AE6B7A00Q57428850-2F024C86-7E04-4E1F-A19B-713807A3A149
P2860
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@ast
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@en
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@nl
type
label
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@ast
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@en
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@nl
prefLabel
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@ast
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@en
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@nl
P2093
P2860
P3181
P1476
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
@en
P2093
Ameya R. Kirtane
Jayanth Panyam
Stephen M. Kalscheuer
P2860
P304
P3181
P356
10.1016/J.ADDR.2013.09.001
P407
P577
2013-11-01T00:00:00Z